← Scroll for more →
Financial Statements — CDRO
Balance Sheet
(in millions EUR)| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 40.31 | 40.43 | 41.28 | 45.40 | 53.80 | 94.90 |
| Total Current Assets | 62.92 | 62.03 | 65.28 | 63.81 | 68.33 | 104.67 |
| Total Non-current Assets | 11.62 | 9.74 | 8.52 | 1.28 | 0.98 | 0.61 |
| Total Assets | 74.54 | 71.78 | 73.80 | 65.09 | 69.31 | 105.28 |
| Total Current Liabilities | 44.96 | 46.68 | 52.11 | 42.48 | 42.75 | 31.61 |
| Total Non-current Liabilities | 5.36 | 6.16 | 0.41 | 0.97 | 2.01 | 5.51 |
| Total Liabilities* | 50.32 | 52.85 | 52.51 | 43.45 | 44.76 | 37.12 |
| Total Stockholder Equity | 24.22 | 18.93 | 21.29 | 21.65 | 24.55 | 68.15 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q2 2024 | Q2 2023 |
|---|---|---|
| Total Revenue | 102.11 | 74.64 |
| Total Operating Expenses | 100.48 | 85.94 |
| Operating Income | 1.63 | (11.31) |
| Pretax Income | 0.67 | (2.74) |
| Tax Provision | (0.92) | 2.42 |
| Net Income | (0.25) | (0.32) |
| Basic EPS | (0.01) | (0.01) |
| Diluted EPS | -- | (0.01) |
← Scroll for more columns →
Cash Flow Statement
(in thousands EUR)| Metric | Q2 2024 | Q2 2023 |
|---|---|---|
| Investing Cash Flow | (202.00) | (76.00) |
| Financing Cash Flow | (222.00) | -- |
← Scroll for more columns →